A detailed history of Rhumbline Advisers transactions in Iradimed Corp stock. As of the latest transaction made, Rhumbline Advisers holds 13,190 shares of IRMD stock, worth $702,103. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,190
Previous 10,969 20.25%
Holding current value
$702,103
Previous $481,000 37.84%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$43.23 - $50.29 $96,013 - $111,694
2,221 Added 20.25%
13,190 $663,000
Q2 2024

Aug 01, 2024

BUY
$40.36 - $44.7 $45,687 - $50,600
1,132 Added 11.51%
10,969 $481,000
Q1 2024

May 09, 2024

BUY
$41.17 - $47.29 $13,133 - $15,085
319 Added 3.35%
9,837 $432,000
Q4 2023

Feb 08, 2024

SELL
$37.31 - $47.47 $3,245 - $4,129
-87 Reduced 0.91%
9,518 $451,000
Q3 2023

Nov 09, 2023

BUY
$43.28 - $50.3 $16,662 - $19,365
385 Added 4.18%
9,605 $426,000
Q2 2023

Aug 08, 2023

SELL
$38.88 - $50.61 $5,248 - $6,832
-135 Reduced 1.44%
9,220 $440,000
Q1 2023

May 11, 2023

BUY
$28.48 - $42.14 $5,809 - $8,596
204 Added 2.23%
9,355 $368,000
Q4 2022

Feb 14, 2023

BUY
$26.9 - $30.58 $7,801 - $8,868
290 Added 3.27%
9,151 $259,000
Q3 2022

Nov 10, 2022

BUY
$29.42 - $42.25 $16,828 - $24,167
572 Added 6.9%
8,861 $266,000
Q2 2022

Aug 11, 2022

BUY
$30.15 - $45.79 $71,274 - $108,247
2,364 Added 39.9%
8,289 $281,000
Q1 2022

May 12, 2022

BUY
$36.01 - $53.14 $26,899 - $39,695
747 Added 14.43%
5,925 $266,000
Q4 2021

Feb 10, 2022

BUY
$32.35 - $48.27 $167,508 - $249,942
5,178 New
5,178 $239,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $669M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.